BE

Bruce Ewenstein

TL Takeda Pharmaceutical Company Limited: 5 patents #285 of 1,531Top 20%
BI Baxalta Incorporated: 3 patents #42 of 230Top 20%
📍 Brookline, MA: #546 of 3,196 inventorsTop 20%
🗺 Massachusetts: #15,851 of 88,656 inventorsTop 20%
Overall (All Time): #613,555 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12156903 Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome Brahm Goldstein, Bernhard Majer, Paolo ROSSATO, Marietta Turecek 2024-12-03
12128090 Methods of prophylactic treatment using recombinant VWF (rVWF) Björn Mellgård 2024-10-29
12016904 Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF Miranda Chapman, Bettina Ploder 2024-06-25
11529395 Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF Miranda Chapman, Bettina Ploder 2022-12-20
11191818 Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome Brahm Goldstein, Bernhard Majer, Paolo ROSSATO, Friedrich Scheiflinger, Marietta Turecek 2021-12-07
10905746 Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF Miranda Chapman, Bettina Ploder 2021-02-02
10632176 Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF Miranda Chapman, Bettina Ploder 2020-04-28
9272021 Treatment of coagulation disease by administration of recombinant VWF Friedrich Scheiflinger, Peter Turecek, Wing Yen Wong, Tobias M. Suiter 2016-03-01